Compare TRDA & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRDA | BPRN |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.6M | 277.1M |
| IPO Year | 2021 | 2022 |
| Metric | TRDA | BPRN |
|---|---|---|
| Price | $6.74 | $41.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 417.4K | 12.1K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | N/A | ★ 74.84 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $25,421,000.00 | N/A |
| Revenue This Year | $39.97 | $9.96 |
| Revenue Next Year | $50.80 | $6.13 |
| P/E Ratio | ★ N/A | $45.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.93 | $29.70 |
| 52 Week High | $16.45 | $43.93 |
| Indicator | TRDA | BPRN |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 67.33 |
| Support Level | $5.80 | $33.15 |
| Resistance Level | $7.34 | N/A |
| Average True Range (ATR) | 0.49 | 1.22 |
| MACD | -0.04 | 0.29 |
| Stochastic Oscillator | 48.26 | 65.51 |
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
Princeton Bancorp Inc is a full-service financial institution providing personal and business banking services, including checking and savings accounts, as well as a range of lending products such as residential, commercial, construction, and consumer loans, including home equity loans and lines of credit. The Bank operates branches and conducts loan origination activities in areas of the New York City metropolitan area. Its loan portfolio is segmented into commercial real estate (including owner-occupied, non-owner-occupied, and multi-family properties), construction loans (mainly for residential developments), commercial and industrial loans (for business purposes), residential real estate loans (secured by one-to-four family properties), and consumer/HELOC loans.